Compare Newegg Commerce Inc (NEGG) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newegg Commerce Inc vs Organon & Co. Common Stock — how do they compare? Newegg Commerce Inc trades at $10.79 (market cap $222.53M), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Organon & Co. Common Stock is far larger — about 16.2× Newegg Commerce Inc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Newegg Commerce Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Newegg Commerce Inc for 14 Days and Organon & Co. Common Stock for 0 Days on average.
| NEGG | OGN | |
|---|---|---|
Market Cap | $222.53M | $3.61B |
Volume | 29,798 | 1,808,049 |
Sector | Consumer Cyclical | Health |
52-Week High | $92.74 | $13.81 |
52-Week Low | $10.61 | $5.70 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $192.77M | $11.03B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $11.13, down 1.94% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $4.88M in 2025, though revenue grew to $1.44B and net income margin improved to -0.34%. Recent news highlights partnerships with Western Digital and Hewlett Packard Enterprise to support AI and IT infrastructure, while insider selling has contributed to negative sentiment.
The outlook is mixed: analyst consensus is a Buy with a $7.75 price target, but the stock faces risks from volatile cash flows, high liabilities, and competitive pressures. Near-term catalysts include the Q3 2026 earnings report and execution on new business initiatives, but investors should weigh improving profitability against persistent operational challenges.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
